5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV

Bioorganic & Medicinal Chemistry Letters
2009.0

Abstract

Dual inhibitors of bacterial gyrB and parE based on a 5-(2-pyrimidinyl)-imidazo[1,2-a]pyridine template exhibited MICs (microg/mL) of 0.06-64 (Sau), 0.25-64 (MRSA), 0.06-64 (Spy), 0.06-64 (Spn), and 0.03-64 (FQR Spn). Selected examples were efficacious in mouse sepsis and lung infection models at <50mg/kg (PO dosing).

Knowledge Graph

Similar Paper

5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV
Bioorganic &amp; Medicinal Chemistry Letters 2009.0
DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: Synthesis and antibacterial activity
Bioorganic &amp; Medicinal Chemistry Letters 2009.0
New N -phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity
European Journal of Medicinal Chemistry 2018.0
Fragment-to-Hit-to-Lead Discovery of a Novel Pyridylurea Scaffold of ATP Competitive Dual Targeting Type II Topoisomerase Inhibiting Antibacterial Agents
Journal of Medicinal Chemistry 2013.0
Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Stucture−Activity Relationships
Journal of Medicinal Chemistry 2008.0
Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design
ACS Medicinal Chemistry Letters 2016.0
Design, synthesis, and structure–activity relationship studies of ATP analogues as DNA gyrase inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2000.0
Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors
European Journal of Medicinal Chemistry 2017.0
Dual Targeting of GyrB and ParE by a Novel Aminobenzimidazole Class of Antibacterial Compounds
Antimicrobial Agents and Chemotherapy 2007.0
An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors
European Journal of Medicinal Chemistry 2019.0